Honestly I think the leukemia/lymphoma (OXS 1550) treatment has the potential to do some good things if they can get it approved or at least far enough to be picked up by one of the bigger pharma companies. I know companies like Kite and Novartis have basically paved the way for "alternative" or second line therapies. I have a family member that's dealing with cancer right now and first hand, I can tell you that the doctors are looking for something that's more effective than just your typical chemo treatment regimen.
As far as soonest to market, they have several therapies in their pipeline that are beyond the investigational phase and into the trial phases like the motion sickness treatment and their therapy for myasthenia gravis.
News 
Market Data 
Discover 
